Search results

Selected filters:

Analysis
Finance

Article type

Topic

Sector

Regions

Year

443 results found for your search

Sort options
14 March 2019

New research highlights impact of patent eligibility uncertainty on life sciences and tech investments

Academic calls for Congress to act on 101 “to restore investor confidence” with private equity and VC players clear that doubts over patentability make it less likely they will part with cash

08 March 2019

IP Bridge approaches milestone transition to private backing

The public-private INCJ is getting ready to exit in the IP business run by Shigeharu Yoshii (pictured, centre). The patent fund operator’s second act will tell us much about Japan’s IP market

21 February 2019

Burford takes aim at opioid overdose medication in series of IPRs

Reviews challenge validity of patents owned by Opiant Pharmaceuticals relating to Narcan brand of naloxone as price of treatments rises

19 February 2019

New Acacia chief IP officer charts a different course for the once mighty NPE

Supported by a healthy balance sheet, Marc Booth says the firm plans on a higher volume of smaller deals with three new areas identified for future growth

15 February 2019

Takeover wars intensify between listed IP firms in Australia

Aggressive move by the country’s largest public IP services group seems designed to thwart the merger of two smaller rivals. But further consolidation in the space still looks likely

12 February 2019

New investment platform aims to break down barriers to capital for innovators

Former IV unit teams up with alternative asset business to give large and small innovators way of attracting finance on Blockchain-based initiative

28 January 2019

Critical condition: has Section 101 put the US medical device sector on life support?

As fears grow over subject-matter eligibility and technological convergence threatens to reshape the competitive landscape, patent strategy has become even more crucial for medical device companies

26 January 2019

An investor's guide to stellar IP due diligence

Private equity funds, VCs and other financial players are beginning to appreciate the value of taking a deep dive into tech company patent holdings, but actually getting a timely and pertinent view is a challenging task 

26 January 2019

Taylor Swift rewrites the rules for licensing

The singer-songwriter is using her industry clout to secure an unprecedented record deal that will also improve the streaming-related revenue of fellow artists.

14 January 2019

Five takeaways from China’s 2018 patent stats

Patent office officials in Beijing reveal the country's top patent recipients, amount of cross-border royalty flows and ambiguous data on foreign firms' patenting activity

28 November 2018

Is McCurdy the man to rescue RPX?

Just months after a private equity takeover, RPX has appointed an industry veteran as its new CEO. But with a declining financial performance and questions remaining over the future of its discovery business, Dan McCurdy (left) will need all of his experience to turn around one of the patent market’s most iconic businesses.

22 November 2018

IP risk management goes mainstream and some see big bucks ahead

Insurance products relating to patents and other rights are not new, but they have never really taken off. Now, though, the industry's heavy hitters are moving in and things could be about to change.

12 November 2018

IP portfolio at stake in fight between EV startup and Chinese investor

Faraday Future says its biggest backer, a Chinese property developer, is deliberately driving it into bankruptcy in order to acquire collateralised intellectual property in a ‘fire sale’.

29 October 2018

Fujifilm spins 900+ patents to Shenzhen firm in $28m deal

O-Film, which supplies camera modules to top smartphone brands, acquires a sizable IP portfolio as part of the deal. It will also take over the Japanese firm's Tianjin-based joint venture business focused on auto.

22 October 2018

Trade secret worries stall $4.1bn Chinese acquisition in Chile

Stake in mining giant would shore up China’s position in the battery tech supply chain. But top shareholder tells Chile’s highest court that the investment could result in loss of trade secrets.